Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Basic Cardiac Electrophysiology and Common Drug-induced Arrhythmias.

Basic Cardiac Electrophysiology and Common Drug-induced Arrhythmias. Critical care nursing clinics of North America Lee, A., Pickham, D. 2016; 28 (3): 357-371

Abstract

Drugs can be a double-edged sword, providing the benefit of symptom alleviation and disease modification but potentially causing harm from adverse cardiac arrhythmic events. Proarrhythmia is the ability of a drug to cause an arrhythmia, the number one reason for drugs to be withdrawn from the patient. Drug-induced arrhythmias are defined as the production of de novo arrhythmias or aggravation of existing arrhythmias, as a result of previous or concomitant pharmacologic treatment. This review summarizes normal cardiac cell and tissue functioning and provides an overview of drugs that effect cardiac repolarization and the adverse effects of commonly administered antiarrhythmics.

View details for DOI 10.1016/j.cnc.2016.04.007

View details for PubMedID 27484663